CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TETZLAFF, J. E.
Right arrow Articles by GELLMAN, M. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by TETZLAFF, J. E.
Right arrow Articles by GELLMAN, M. D.

Canadian Journal of Anesthesia, Vol 33, 647-650, Copyright © 1986 by Canadian Anesthesiologists' Society

Clinical Reports: Anaphylactoid Reaction to Atracurium

JOHN E. TETZLAFF LCDR MC USNR1 and MICHAEL D. GELLMAN CDR MC USNR1

1 Department of Anesthesiology, Naval Hospital, Portsmouth, Virginia, 23708

correspondence should be addressed to Dr. Tetzlaff.

Atracurium is a new intermediate-acting muscle relaxant, relatively devoid of cardiovascular effect in the clinical dose range. Histamine release is reported in a dose-dependent fashion, but below the threshold for haemodynamic effect within the recommended dose limits. We report a case of an anaphylactoid reaction to a low dose (0.2 mg·kg-1) of atracurium, and discuss the peculiar aspects of this case that predisposed the patient to this event.

Key Words: COMPLICATIONS: anaphylaxis, anaphylactoid reaction • MUSCLE RELAXANTS: atracurium






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the Canadian Anesthesiologists' Society.